Nu Skin is one of ten public companies that Forbes lists as a BUY with a picture of Tru Face Essence Ultra in the article.
- Galvanic SPA Sales rose 500% in 2008 over 2007
- The # of New Ruby Execs ($36K) rose 64% in 2008 over 2007
- The # of New Blue Diamond Execs ($500K+) rose 26% in 2008 over 2007
- Nu Skin creates a NEW Millionaire EVERY TEN DAYS!
- A NEW Thousandaire EVERY 90 minutes!!!
- 2008 was the biggest revenue year in NSE history
- December was the biggest revenue December in NSE history
Anti-Age Product Could Lift Nu Skin; Dividend Rising
BY PAUL WHITFIELD
INVESTOR’S BUSINESS DAILY
A new product, if successful, can accelerate sales and earnings growth.
Utah-based Nu Skin Enterprises (NUS) plans to roll out an anti-aging product in January that, if not a fountain of youth, might be at least a sprinkler of youth.
Professors at Purdue University and the Stanford School of Medicine, along with Nu Skin researchers, discovered an enzyme that affects a person’s appearance.
According to a study conducted at Stanford, people with high levels of arNox, the enzyme, look about seven years older than those with low levels of it.
Nu Skin’s new product ageLoc contains an ingredient that the company says can inhibit the enzyme.
If it works, the next question is how much it can boost the bottom line of this direct seller of personal care and nutrition supplements.
Nu Skin sees great potential in the new product.
“This is a platform change for us,” Chief Executive Truman Hunt told IBD on Wednesday. “The market is not yet focused on where we are.”
Most anti-aging products focus on masking symptoms. Hunt said ageLoc is addressing the source.
Apart from the new product, Nu Skin has some features attractive to income investors.
It has paid dividends since 2001 and increased the payout seven straight years.
